GTF2I Antikörper (C-Term)
Kurzübersicht für GTF2I Antikörper (C-Term) (ABIN453078)
Target
Alle GTF2I Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- This antibody detects GTF2I / TFII-I at C-term.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human
-
Aufreinigung
- Purified through a protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide selected from the C-terminal region of human GTF2I
-
-
-
-
Applikationshinweise
-
Western blot: 1: 100 - 1: 500. ELISA: 1: 1,000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
-
-
- GTF2I (General Transcription Factor III (GTF2I))
-
Andere Bezeichnung
- GTF2I / TFII-I
-
Hintergrund
- GTF2I is a multifunctional phosphoprotein with roles in transcription and signal transduction. It is deleted in Williams-Beuren syndrome, a multisystem developmental disorder caused by the deletion of contiguous genes at chromosome 7q11.23.Synonyms: BAP-135, BAP135, Bruton tyrosine kinase-associated protein 135, GTFII-I, General transcription factor II-I, SPIN, SRF-Phox1-interacting protein, WBSCR6, Williams-Beuren syndrome chromosomal region 6 protein
-
Molekulargewicht
- 112416 Da
-
Gen-ID
- 2969
-
NCBI Accession
- NP_001509
-
UniProt
- P78347
Target
-